Question 1

What is this medicine for, and how does it work?

Accepted Answer

This is a pyrimidine antimetabolite. It works by interfering with DNA and RNA synthesis to prevent cancer cell growth. It is used to treat leukemia and other cancers.

Question 2

When and how should this medicine be taken?

Accepted Answer

• For hospital use only • Can be given IV or subcutaneous • Requires medical supervision

Question 3

When should this medicine not be used?

Accepted Answer

• Do not use during pregnancy • Do not use if you have severely low blood cell counts • Use with caution if you have brain problems

Question 4

What precautions should be taken before using this medicine?

Accepted Answer

• Use carefully in patients with previous bone marrow problems • Use with caution in patients with liver or kidney issues • Not recommended during pregnancy or breastfeeding • Regular blood tests needed

Question 5

Is it safe to use this medicine during pregnancy?

Accepted Answer

• Not safe during pregnancy; • May cause fetal harm; • Avoid use

Question 6

Can this medicine be used while breastfeeding?

Accepted Answer

• Use carefully in patients with previous bone marrow problems • Use with caution in patients with liver or kidney issues • Not recommended during pregnancy or breastfeeding • Regular blood tests needed

Question 7

What should be done if a dose is missed?

Accepted Answer

• If you miss a dose, take it as soon as you remember. • However, if it's time for your next dose, skip the missed dose. • Never take two doses in one day. • For twice-daily dosing: If less than 6 hours until your next dose, skip the missed dose. • Take your next dose at the regular time. • If you miss multiple doses, contact your doctor.

Question 8

What should be done in case of an overdose?

Accepted Answer

• Overdose symptoms: Bone marrow suppression, neurotoxicity. • Treatment: Supportive care, consider G-CSF.

Question 9

What should be done if side effects are experienced?

Accepted Answer

• Common side effects: Loss of appetite, mouth sores, low blood counts, skin rash • What to do: Regular blood tests; Report fever; Mouth care routine; Stop taking the medication and seek medical advice if any severe side effect or unusual symptoms occur.

Question 10

What is Cytarabine 5ml 100mg/5ml used for?

Accepted Answer

Cytarabine 5ml 100mg/5ml (Cytarabine) is a pharmaceutical medicine manufactured by Choongwae Pharma Corporation,Korea in Bangladesh. It is primarily prescribed for Acute Lymphocytic Leukemia, Acute Myeloid Leukemia (AML), Leukaemic Meningitis, Lymphoma.

Question 11

What is the active generic component of Cytarabine 5ml?

Accepted Answer

The active ingredient in Cytarabine 5ml is Cytarabine, belonging to the Antimetabolites drug class.

Question 12

What is the retail price of Cytarabine 5ml 100mg/5ml in Bangladesh?

Accepted Answer

The official retail price of Cytarabine 5ml 100mg/5ml (Injection) is ৳180.00 in Bangladesh (prices may vary slightly by pack size and authorized pharmacy).

Question 13

What is the recommended dosage for Cytarabine 5ml?

Accepted Answer

Standard adult dosage: Intravenous administration – 100-200 mg/square meter/day. Pediatric dosage: Intravenous – 100 mg/m2/day (continuous intravenous infusion). Always consult a registered physician for individualized dosage adjustments based on clinical assessment.

Question 14

Is Cytarabine 5ml safe during pregnancy and breastfeeding?

Accepted Answer

Cytarabine 5ml is classified under Pregnancy Category "D". Always consult your healthcare provider or OB/GYN before taking this medication during pregnancy or lactation.

Question 15

What are the common side effects of Cytarabine 5ml?

Accepted Answer

**1-10%**; Anorexia;Nausea;Vomiting;Diarrhea;Oral/anal inflammation;Thrombophlebitis;Bleeding;Myelosuppression;Rash;Fever;Hepatic dysfunction; **Frequency Not Defined**; Headache;Neuropathy;Chest pain;Pericarditis;Pneumo

Clinical Information	Administration Information
Indication: Acute Nonlymphocytic Leukemia Condition: Remission induction	Dose: Intravenous administration – 100-200 mg/square meter/day Duration: 5-10 days Note: Begin second course in 2-4 weeks after initial therapy if necessary
Indication: Acute Nonlymphocytic Leukemia Condition: Remission induction	Dose: Intravenous administration – 100 mg/square meter Duration: 7 days

Clinical Information	Administration Information
Indication: Remission induction in acute non-lymphocytic leukemia Age: Pediatric patients	Dose: Intravenous – 100 mg/m2/day Frequency: continuous intravenous infusion Duration: 7 days
Indication: Remission induction in acute non-lymphocytic leukemia Age: Pediatric patients	Dose: Intravenous – 100 mg/m2 Frequency: every 12 hours Duration: 7 days

Drug Name	Risk Factors
Gentamicin, digoxin, flucytosine	May reduce efficacy
Radiotherapy, other myelotoxic drugs	Potentially Fatal: Potentiates bone marrow depression

Medicine Overview

Indication

What is this medicine for, and how does it work?

When and how should this medicine be taken?

When should this medicine not be used?

What precautions should be taken before using this medicine?

Is it safe to use this medicine during pregnancy?

Can this medicine be used while breastfeeding?

What should be done if a dose is missed?

What should be done in case of an overdose?

What should be done if side effects are experienced?

Adult Dose

Child Dose

Drug Interaction

Disease Interaction

Pregnancy

Data Sources